Rocket Pharmaceuticals, Inc. (RCKT)
3.665
-0.12
(-3.04%)
USD |
NASDAQ |
Aug 26, 16:00
3.665
0.00 (0.00%)
After-Hours: 20:00
Rocket Pharmaceuticals Shareholders Equity (Quarterly) : 368.83M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 368.83M |
| March 31, 2026 | 238.04M |
| December 31, 2025 | 277.22M |
| September 30, 2025 | 313.67M |
| June 30, 2025 | 354.21M |
| March 31, 2025 | 412.14M |
| December 31, 2024 | 463.23M |
| September 30, 2024 | 329.77M |
| June 30, 2024 | 384.64M |
| March 31, 2024 | 441.50M |
| December 31, 2023 | 492.57M |
| September 30, 2023 | 541.09M |
| June 30, 2023 | 402.97M |
| March 31, 2023 | 458.88M |
| December 31, 2022 | 489.69M |
| September 30, 2022 | 367.31M |
| June 30, 2022 | 387.70M |
| March 31, 2022 | 417.62M |
| December 31, 2021 | 454.72M |
| September 30, 2021 | 485.66M |
| June 30, 2021 | 489.44M |
| March 31, 2021 | 480.00M |
| December 31, 2020 | 503.52M |
| September 30, 2020 | 241.84M |
| June 30, 2020 | 266.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 286.05M |
| December 31, 2019 | 307.30M |
| September 30, 2019 | 231.92M |
| June 30, 2019 | 248.50M |
| March 31, 2019 | 177.08M |
| December 31, 2018 | 194.04M |
| September 30, 2018 | 143.62M |
| June 30, 2018 | 157.08M |
| March 31, 2018 | 170.15M |
| December 31, 2017 | 15.52M |
| September 30, 2017 | 51.08M |
| June 30, 2017 | 57.53M |
| March 31, 2017 | 63.26M |
| December 31, 2016 | 73.17M |
| September 30, 2016 | 85.05M |
| June 30, 2016 | 95.44M |
| March 31, 2016 | 99.24M |
| December 31, 2015 | 108.81M |
| September 30, 2015 | 116.48M |
| June 30, 2015 | 31.72M |
| March 31, 2015 | 33.95M |
| December 31, 2014 | -4.758M |
| September 30, 2014 | -2.61M |
| June 30, 2014 | |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 423.10M |
| Total Liabilities (Quarterly) | 54.27M |
| Debt to Equity Ratio | 0.0672 |
| Current Ratio | 9.245 |
| Net Debt Paydown Yield | 0.03% |